It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GNW’s FA Score shows that 1 FA rating(s) are green whileMET’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GNW’s TA Score shows that 5 TA indicator(s) are bullish while MET’s TA Score has 4 bullish TA indicator(s).
GNW (@Life/Health Insurance) experienced а +1.92% price change this week, while MET (@Life/Health Insurance) price change was +1.89% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +1.43%. For the same industry, the average monthly price growth was +7.44%, and the average quarterly price growth was +13.68%.
GNW is expected to report earnings on Oct 29, 2024.
MET is expected to report earnings on Oct 30, 2024.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
GNW | MET | GNW / MET | |
Capitalization | 2.85B | 53.3B | 5% |
EBITDA | N/A | N/A | - |
Gain YTD | 3.144 | 30.134 | 10% |
P/E Ratio | 39.63 | 40.71 | 97% |
Revenue | 7.37B | 66.4B | 11% |
Total Cash | 49B | 308B | 16% |
Total Debt | 1.58B | 18.8B | 8% |
GNW | MET | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 38 Fair valued | |
PROFIT vs RISK RATING 1..100 | 38 | 16 | |
SMR RATING 1..100 | 98 | 99 | |
PRICE GROWTH RATING 1..100 | 52 | 21 | |
P/E GROWTH RATING 1..100 | 1 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (38) in the Life Or Health Insurance industry is in the same range as GNW (70). This means that MET’s stock grew similarly to GNW’s over the last 12 months.
MET's Profit vs Risk Rating (16) in the Life Or Health Insurance industry is in the same range as GNW (38). This means that MET’s stock grew similarly to GNW’s over the last 12 months.
GNW's SMR Rating (98) in the Life Or Health Insurance industry is in the same range as MET (99). This means that GNW’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (21) in the Life Or Health Insurance industry is in the same range as GNW (52). This means that MET’s stock grew similarly to GNW’s over the last 12 months.
GNW's P/E Growth Rating (1) in the Life Or Health Insurance industry is significantly better than the same rating for MET (100). This means that GNW’s stock grew significantly faster than MET’s over the last 12 months.
GNW | MET | |
---|---|---|
RSI ODDS (%) | 3 days ago74% | 2 days ago57% |
Stochastic ODDS (%) | 2 days ago75% | 2 days ago59% |
Momentum ODDS (%) | 2 days ago76% | 2 days ago67% |
MACD ODDS (%) | 2 days ago65% | 2 days ago58% |
TrendWeek ODDS (%) | 2 days ago68% | 2 days ago63% |
TrendMonth ODDS (%) | 2 days ago63% | 2 days ago60% |
Advances ODDS (%) | 16 days ago71% | 9 days ago66% |
Declines ODDS (%) | 3 days ago68% | about 1 month ago52% |
BollingerBands ODDS (%) | 2 days ago84% | 2 days ago57% |
Aroon ODDS (%) | 2 days ago66% | 2 days ago62% |
A.I.dvisor indicates that over the last year, GNW has been loosely correlated with CNO. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if GNW jumps, then CNO could also see price increases.